Sign in to view content

Ixoberogene Soroparvovec (Ixo-vec) IVT Gene Therapy for Neovascular AMD: First Time 26-Week Interim Analysis Results from the Phase 2 LUNA Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2024

Related

Subthreshold Micropulse Yellow Laser Photocoagulation in Macular Edema Refractory to Anti-VEGF Treatment in Case of BRVO
MATTEO M FORLINI, MD
On Demand Cases, Courses, and Papers
2019
Quality Assessment of a New Silicone-Free Syringe Developed for Intravitreal Injections
Gustavo Barreto de Melo, MD, PhD, FASRS
On Demand Cases, Courses, and Papers
2021
Results of Perimetry at Age of 10 Years in Severe ROP Eyes Receiving Laser or Anti-VEGF Treatment as Primary Monotherapy
Alay S. Banker, MD
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more